Contact dermatitis
Conditions
Interventions
Experimental group: 18 participants, of both sexes, aged 18 to 65 years and phototypes of I to IV (according to Fitzpatrick's classification), susceptible to the appearance of contact wound and / or d
Device
Genetics
Sponsors
Ipclin - Pesquisa Clínica Integrada
TCI Laboratório Biotecnológico LTDA.
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 18 to 65 years; Female or male; Phototypes I to IV; Subjects susceptible to the appearance of wound and/or contact dermatitis; Able to follow the guidelines and reliable to respect the restrictions of the protocol.
Exclusion criteria
Exclusion criteria: Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (pigmentation disorders, vascular malformations, scars, increased hairiness, ephelides and nevus in large quantities, sunburn); Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; History of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Participants with a history of allergy to the material used in the study; History of atopy; History of conditions aggravated or triggered by ultraviolet radiation; Immunodeficiency carriers; Renal, cardiac or hepatic transplanted; Intense sun exposure or tanning session up to 15 days prior to initial assessment; Prediction of intense sun exposure or the tanning session during the period of study conduction; Forecast to take a bath, pool or sauna during the study; Participants who practice water sports; Use of the following topical systemic medications: immunosuppressants, antihistamines, non-hormonal anti-inflammatories, and corticosteroids up to two weeks prior to selection; Treatment with acid vitamin A and / or its derivatives orally or topically up to 01 month before the start of the study; Prediction of vaccination during the study or until 03 weeks before the study; Be participating in another study; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study; History of absence of adherence or unwillingness to adhere to the study protocol; Professionals directly involved in the accomplishment of this protocol and their relatives.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in skin conditions, identified by counting of positive responses from research participants, after completing a questionnaire of appreciability and post-intervention medical evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactCassiano Escudeiro
Ipclin - Pesquisa Clínica Integrada
Outcome results
None listed